Manager - Clinical Central Services & Innovation Telemedicine and Virtual Orchestration

Cork, County Cork, Ireland

Auto‑apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Biotechnology, Clinical ResearchIndustries

Requirements

Candidates should possess a Bachelor’s degree in a related field, along with a minimum of 7 years of experience in clinical operations, preferably within a pharmaceutical or biotechnology company. Demonstrated experience in clinical trial management, with a focus on decentralized clinical trials (DCTs) and telemedicine is essential. Strong project management skills and the ability to lead cross-functional teams are also required.

Responsibilities

The Manager will orchestrate solutions that enhance clinical research awareness and accessibility while increasing diversity, reducing burden and speeding trial execution by partnering across functions within Clinical Design, Delivery and Analytics (CDDA) and Product Research and Development (PRD). They will also influence trial design and operationalize innovation solutions to support the execution of clinical trials globally for all business units across all phases of development, leveraging telemedicine and virtual orchestration to create a more patient-centric experience in clinical trials.

Skills

Clinical Trial Management

Decentralized Clinical Trials (DCTs)

Telemedicine

Project Management

Cross-functional Team Leadership

Clinical Operations

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free